Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Managed Health Care - NEC
- Sub-Industry: Managed Health Care
- Symbol: NYSE:CNC
- CUSIP: 15135B10
- Web: www.centene.com
- Market Cap: $14.59709 billion
- Outstanding Shares: 172,277,000
- 50 Day Moving Avg: $80.70
- 200 Day Moving Avg: $72.76
- 52 Week Range: $50.00 - $86.02
Sales & Book Value:
- Trailing P/E Ratio: 20.73
- Foreward P/E Ratio: 15.80
- P/E Growth: 1.36
- Annual Revenue: $42.47 billion
- Price / Sales: 0.34
- Book Value: $35.24 per share
- Price / Book: 2.39
- EBIDTA: $2.12 billion
- Net Margins: 1.57%
- Return on Equity: 14.19%
- Return on Assets: 4.09%
- Debt-to-Equity Ratio: 0.76%
- Current Ratio: 1.02%
- Quick Ratio: 1.02%
- Average Volume: 1.73 million shs.
- Beta: 0.67
- Short Ratio: 1.82
Frequently Asked Questions for Centene Corporation (NYSE:CNC)
What is Centene Corporation's stock symbol?
Centene Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
How were Centene Corporation's earnings last quarter?
Centene Corporation (NYSE:CNC) announced its quarterly earnings data on Tuesday, July, 26th. The company reported $1.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.09 by $0.20. The business earned $10.90 billion during the quarter, compared to analyst estimates of $10.80 billion. Centene Corporation had a net margin of 1.57% and a return on equity of 14.19%. The company's revenue was up 97.9% on a year-over-year basis. During the same period last year, the firm posted $0.72 EPS. View Centene Corporation's Earnings History.
When will Centene Corporation make its next earnings announcement?
Where is Centene Corporation's stock going? Where will Centene Corporation's stock price be in 2017?
18 brokers have issued 12 month price targets for Centene Corporation's stock. Their predictions range from $64.00 to $95.00. On average, they expect Centene Corporation's stock price to reach $82.31 in the next year. View Analyst Ratings for Centene Corporation.
What are analysts saying about Centene Corporation stock?
Here are some recent quotes from research analysts about Centene Corporation stock:
- 1. According to Zacks Investment Research, "Centene has seen substantial inorganic growth in the last five years. The acquisition of Health Net in 2016 which boosted the company’s growth, expansion and asset base, is worth a mention here. This apart, its solid financial position provides a major boost to its capital deployment initiatives. The company’s strong Managed care segment also impresses. Well evident of all these tailwinds, year to date, the stock rallied 44%, outpacing 210% gain of the Zacks HMO industry. The company’s strong and consistent performance is likely to have generated confidence among the investors. However, the company rigorously suffers from continuously rising level of debt that result in increasing borrowing cost which again keeps draining the bottom line. In addition, steep increase in acquisition related expenses as well as the regulatory uncertainty from the change of presidency are major concerns." (7/10/2017)
- 2. Cantor Fitzgerald analysts commented, "This morning, CNC reported 1Q17 results. Revenue of $11.7 billion was slightly ahead of FactSet consensus. Adjusted EPS was $1.12 vs. our estimate." (4/25/2017)
- 3. Leerink Swann analysts commented, "We reiterate our Market Perform rating on CNC while raising PT to $64 from $62 after the 4Q report and almost 6% move up yesterday." (2/9/2017)
Who are some of Centene Corporation's key competitors?
Some companies that are related to Centene Corporation include Incyte Corporation (INCY), Zimmer Biomet Holdings (ZBH), Illumina (ILMN), Astellas Pharma (ALPMY), Edwards Lifesciences Corporation (EW), Cardinal Health (CAH), C.R. Bard (BCR), Cerner Corporation (CERN), Mylan N.V. (MYL), AmerisourceBergen Corporation (Holding Co) (ABC), Quintiles Transitional Holdings (Q), Lonza Group Ag (LZAGY), Laboratory Corporation of America Holdings (LH), BioMarin Pharmaceutical (BMRN), Eisai Co., Ltd (ESALY), Smith & Nephew SNATS (SNN), Quest Diagnostics Incorporated (DGX) and IDEXX Laboratories (IDXX).
Who are Centene Corporation's key executives?
Centene Corporation's management team includes the folowing people:
- Michael F. Neidorff, Chairman of the Board, President, Chief Executive Officer
- Jeffrey A. Schwaneke CPA, Chief Financial Officer, Executive Vice President, Treasurer
- Keith H. Williamson, Executive Vice President, General Counsel, Secretary
- Christopher D. Bowers, Executive Vice President - Marketing
- Cynthia J. Brinkley, Executive Vice President - Global Corporate Development
- Jesse N. Hunter, Executive Vice President - Products
- Christopher R. Isaak, Senior Vice President, Corporate Controller and Chief Accounting Officer
- Mark J. Brooks, Senior Vice President, Chief Information Officer
- Christopher A. Koster, Senior Vice President - Corporate Services
- Orlando Ayala, Independent Director
Who owns Centene Corporation stock?
Centene Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (0.34%), Bank of Montreal Can (0.22%), First Quadrant L P CA (0.21%), BB&T Corp (0.12%), National Pension Service (0.10%) and Chevy Chase Trust Holdings Inc. (0.09%). Company insiders that own Centene Corporation stock include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt and Robert K Ditmore. View Institutional Ownership Trends for Centene Corporation.
Who sold Centene Corporation stock? Who is selling Centene Corporation stock?
Centene Corporation's stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., APG Asset Management N.V., Osborne Partners Capital Management LLC, Vaughan Nelson Investment Management L.P., Handelsbanken Fonder AB, Independent Portfolio Consultants Inc., BB&T Corp and NN Investment Partners Holdings N.V.. Company insiders that have sold Centene Corporation stock in the last year include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt and Robert K Ditmore. View Insider Buying and Selling for Centene Corporation.
Who bought Centene Corporation stock? Who is buying Centene Corporation stock?
Centene Corporation's stock was bought by a variety of institutional investors in the last quarter, including First Quadrant L P CA, Bank of Montreal Can, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Meeder Asset Management Inc., Mn Services Vermogensbeheer B.V., National Pension Service, Bank of The West and Polianta Ltd. View Insider Buying and Selling for Centene Corporation.
How do I buy Centene Corporation stock?
Shares of Centene Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene Corporation's stock price today?
MarketBeat Community Rating for Centene Corporation (NYSE CNC)MarketBeat's community ratings are surveys of what our community members think about Centene Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Centene Corporation stock can currently be purchased for approximately $84.20.
Consensus Ratings for Centene Corporation (NYSE:CNC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||5 Hold Ratings, 13 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.72)|
|Consensus Price Target: ||$82.31 (2.24% downside)|
Analysts' Ratings History for Centene Corporation (NYSE:CNC)
(Data available from 7/25/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|7/14/2017||Jefferies Group LLC||Reiterated Rating||Buy||$94.00||Low|
|7/14/2017||Bank of America Corporation||Boost Price Target||Buy||$93.00 -> $95.00||Low|
|7/13/2017||Deutsche Bank AG||Boost Price Target||Buy||$84.00 -> $92.00||Low|
|7/11/2017||Sanford C. Bernstein||Reiterated Rating||Outperform||Medium|
|6/19/2017||Credit Suisse Group||Reiterated Rating||Neutral||$78.00 -> $81.00||Low|
|6/19/2017||Cantor Fitzgerald||Reiterated Rating||Overweight||$88.00 -> $90.00||Low|
|6/6/2017||Morgan Stanley||Initiated Coverage||Overweight -> Overweight||$86.00||Medium|
|5/22/2017||J P Morgan Chase & Co||Downgrade||Overweight -> Neutral||$75.00||Medium|
|4/26/2017||Evercore ISI||Boost Price Target||Outperform||$80.00 -> $83.00||High|
|4/26/2017||Stifel Nicolaus||Boost Price Target||Buy||$80.00 -> $85.00||High|
|3/23/2017||Citigroup Inc.||Downgrade||Buy -> Neutral||$73.00||High|
|2/9/2017||Leerink Swann||Reiterated Rating||Market Perform||$62.00 -> $64.00||N/A|
|2/8/2017||Piper Jaffray Companies||Boost Price Target||Overweight||$67.00 -> $76.00||N/A|
|2/8/2017||Barclays PLC||Boost Price Target||Overweight||$75.00 -> $79.00||N/A|
|12/20/2016||Oppenheimer Holdings, Inc.||Reiterated Rating||Outperform||N/A|
|12/13/2016||Goldman Sachs Group, Inc. (The)||Upgrade||Sell -> Neutral||N/A|
|9/1/2016||FBR & Co||Reiterated Rating||Buy||N/A|
|6/28/2016||Wolfe Research||Initiated Coverage||Market Perform||$80.00||N/A|
|6/20/2016||Cowen and Company||Reiterated Rating||Buy||N/A|
|6/20/2016||Wells Fargo & Company||Reiterated Rating||Buy||N/A|
Earnings History for Centene Corporation (NYSE:CNC)Earnings History by Quarter for Centene Corporation (NYSE CNC)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/25/2017||Q1 17||$1.06||$1.12||$11.44 billion||$11.72 billion||View||N/A|
|2/7/2017||Q416||$1.11||$1.19||$10.94 billion||$11.91 billion||View||N/A|
|10/25/2016||Q316||$1.15||$1.11||$10.96 million||$10.85 billion||View||Listen|
|7/26/2016||Q216||$1.09||$1.29||$10.80 billion||$10.90 billion||View||Listen|
|4/26/2016||Q116||$0.74||$0.74||$7.88 billion||$6.95 billion||View||Listen|
|2/9/2016||Q415||$0.82||$0.95||$6.14 billion||$6.30 billion||View||N/A|
|10/27/2015||Q315||$0.78||$0.84||$5.79 billion||$5.82 billion||View||Listen|
|7/28/2015||Q215||$0.69||$0.73||$5.54 billion||$5.51 billion||View||Listen|
|4/28/2015||Q115||$0.48||$0.52||$5.12 billion||$5.13 billion||View||Listen|
|2/3/2015||Q414||$1.70||$1.74||$4.62 billion||$4.42 billion||View||Listen|
|10/28/2014||Q314||$0.96||$1.22||$4.23 billion||$4.35 billion||View||Listen|
|7/22/2014||Q214||$0.73||$0.79||$3.66 billion||$4.02 billion||View||Listen|
|4/22/2014||Q1||$0.44||$0.57||$3.25 billion||$3.35 billion||View||Listen|
|2/4/2014||Q413||$0.83||$0.84||$2.93 billion||$2.86 billion||View||Listen|
|10/22/2013||Q313||$0.84||$0.87||$2.68 billion||$2.70 billion||View||Listen|
|7/23/2013||Q2 2013||$0.62||$0.77||$2.63 billion||$2.73 billion||View||Listen|
|4/23/2013||Q1 2013||$0.38||$0.42||$2.46 billion||$2.54 billion||View||Listen|
|2/5/2013||Q4 2012||$0.32||$0.17||$2.40 billion||$2.30 billion||View||Listen|
Earnings Estimates for Centene Corporation (NYSE:CNC)
2017 EPS Consensus Estimate: $4.70
2018 EPS Consensus Estimate: $5.36
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Centene Corporation (NYSE:CNC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Centene Corporation (NYSE:CNC)
Insider Ownership Percentage: 3.00%Insider Trades by Quarter for Centene Corporation (NYSE:CNC)
Institutional Ownership Percentage: 93.51%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|7/6/2017||Michael F. Neidorff||Chairman||Sell||35,000||$80.26||$2,809,100.00|| |
|6/12/2017||Richard A. Gephardt||Director||Sell||4,350||$77.38||$336,603.00|| |
|6/2/2017||Mark J. Brooks||SVP||Sell||2,161||$75.43||$163,004.23|| |
|6/2/2017||Robert K. Ditmore||Director||Sell||3,900||$75.43||$294,177.00|| |
|5/1/2017||Jesse N. Hunter||EVP||Sell||5,000||$74.40||$372,000.00|| |
|4/27/2017||Christopher D. Bowers||EVP||Sell||3,150||$72.80||$229,320.00|| |
|4/27/2017||Robert K. Ditmore||Director||Sell||4,167||$72.43||$301,815.81|| |
|3/27/2017||Keith H. Williamson||EVP||Sell||6,000||$70.03||$420,180.00|| |
|3/13/2017||Jeffrey A. Schwaneke||CFO||Sell||2,000||$68.52||$137,040.00|| |
|2/13/2017||Jesse N. Hunter||EVP||Sell||5,000||$69.54||$347,700.00|| |
|12/1/2016||Mark J. Brooks||SVP||Sell||1,099||$58.00||$63,742.00|| |
|11/7/2016||Jesse N. Hunter||EVP||Sell||5,000||$65.00||$325,000.00|| |
|10/3/2016||Carol Goldman||VP||Sell||10,000||$66.36||$663,600.00|| |
|10/3/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$66.58||$399,480.00|| |
|9/7/2016||Robert K. Ditmore||Director||Buy||150||$67.00||$10,050.00|| |
|7/1/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$71.00||$426,000.00|| |
|6/29/2016||Richard A. Gephardt||Director||Sell||15,910||$68.89||$1,096,039.90|| |
|6/24/2016||Keith H. Williamson||EVP||Sell||4,000||$70.00||$280,000.00|| |
|6/6/2016||Mark J Brooks||SVP||Sell||3,914||$65.01||$254,449.14|| |
|4/28/2016||Jesse N Hunter||EVP||Sell||10,000||$65.17||$651,700.00|| |
|4/1/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$60.87||$365,220.00|| |
|3/23/2016||Carol Goldman||VP||Sell||15,000||$62.96||$944,400.00|| |
|1/4/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$64.68||$388,080.00|| |
|12/22/2015||Carol Goldman||VP||Sell||25,000||$65.19||$1,629,750.00|| |
|12/22/2015||Jeffrey A Schwaneke||CAO||Sell||2,000||$65.09||$130,180.00|| |
|10/29/2015||Carol Goldman||VP||Sell||5,000||$60.88||$304,400.00|| |
|7/1/2015||Carol Goldman||VP||Sell||5,000||$81.20||$406,000.00|| |
|6/22/2015||Keith H Williamson||EVP||Sell||7,000||$80.87||$566,090.00|| |
|6/18/2015||William N Scheffel||CFO||Sell||25,290||$79.14||$2,001,450.60|| |
|5/4/2015||Donald G Imholz||EVP||Sell||5,000||$65.08||$325,400.00|| |
|4/30/2015||Carol Goldman||VP||Sell||15,998||$63.48||$1,015,553.04|| |
|4/30/2015||Donald G Imholz||EVP||Sell||5,000||$63.72||$318,600.00|| |
|4/30/2015||Robert K Ditmore||Director||Sell||15,000||$63.83||$957,450.00|| |
|4/6/2015||Michael F Neidorff||CEO||Sell||10,000||$70.43||$704,300.00|| |
|4/1/2015||Jesse N Hunter||EVP||Sell||5,000||$69.66||$348,300.00|| |
|3/19/2015||Keith H Williamson||EVP||Sell||5,000||$70.18||$350,900.00|| |
|3/13/2015||Tommy G Thompson||Director||Sell||16,000||$65.36||$1,045,760.00|| |
|3/9/2015||Robert K Ditmore||Director||Sell||15,000||$63.19||$947,850.00|| |
|1/2/2015||Carol Goldman||VP||Sell||8,400||$104.87||$880,908.00|| |
|1/2/2015||Jesse N Hunter||EVP||Sell||2,500||$104.87||$262,175.00|| |
|12/16/2014||Jeffrey A Schwaneke||CAO||Sell||5,000||$101.80||$509,000.00|| |
|10/1/2014||Jesse N Hunter||EVP||Sell||2,500||$81.42||$203,550.00|| |
|9/22/2014||Carol Goldman||VP||Sell||12,500||$81.85||$1,023,125.00|| |
|9/18/2014||Donald G Imholz||EVP||Sell||5,000||$80.10||$400,500.00|| |
|9/15/2014||Keith H Williamson||EVP||Sell||4,000||$77.48||$309,920.00|| |
|9/9/2014||Jeffrey A Schwaneke||CAO||Sell||1,000||$79.51||$79,510.00|| |
|9/9/2014||Jesse N Hunter||EVP||Sell||5,000||$79.35||$396,750.00|| |
|9/2/2014||Donald G Imholz||EVP||Sell||5,000||$77.32||$386,600.00|| |
|8/28/2014||Jeffrey A Schwaneke||CAO||Sell||1,000||$77.02||$77,020.00|| |
|5/12/2014||Jason Harrold||EVP||Sell||2,500||$70.00||$175,000.00|| |
|4/2/2014||Jason Harrold||EVP||Sell||5,000||$62.19||$310,950.00|| |
|3/31/2014||Edmund Kroll||SVP||Sell||5,000||$62.00||$310,000.00|| |
|3/31/2014||William Scheffel||CFO||Sell||17,895||$61.99||$1,109,311.05|| |
|2/6/2014||Jesse Hunter||EVP||Sell||5,000||$61.66||$308,300.00|| |
|2/6/2014||Michael Neidorff||CEO||Sell||10,000||$62.00||$620,000.00|| |
|12/17/2013||Orlando Ayala||Director||Buy||17,600||$56.41||$992,816.00|| |
|7/25/2013||Jeffrey A Schwaneke||CAO||Sell||3,000||$57.40||$172,200.00|| |
|7/25/2013||Jesse N Hunter||EVP||Sell||5,000||$57.41||$287,050.00|| |
|6/13/2013||Keith H Williamson||EVP||Sell||5,800||$50.25||$291,450.00|| |
|6/7/2013||Donald G Imholz||EVP||Sell||5,000||$50.00||$250,000.00|| |
|6/3/2013||Carol Goldman||VP||Sell||10,000||$49.28||$492,800.00|| |
|6/3/2013||Jesse N Hunter||EVP||Sell||6,000||$48.28||$289,680.00|| |
|5/30/2013||Jason M Harrold||EVP||Sell||5,000||$50.80||$254,000.00|| |
|5/30/2013||Jeffrey A Schwaneke||CAO||Sell||3,000||$50.68||$152,040.00|| |
|5/30/2013||William N Scheffel||CFO||Sell||22,191||$50.80||$1,127,302.80|| |
|5/10/2013||Keith H Williamson||EVP||Sell||3,000||$50.00||$150,000.00|| |
|12/4/2012||Carol Goldman||VP||Sell||15,000||$45.15||$677,250.00|| |
|12/4/2012||Keith H Williamson||EVP||Sell||9,000||$45.10||$405,900.00|| |
Headline Trends for Centene Corporation (NYSE:CNC)
Latest Headlines for Centene Corporation (NYSE:CNC)
Centene Corporation (CNC) Chart for Tuesday, July, 25, 2017